These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31479437)

  • 1. Benchmarking network propagation methods for disease gene identification.
    Picart-Armada S; Barrett SJ; Willé DR; Perera-Lluna A; Gutteridge A; Dessailly BH
    PLoS Comput Biol; 2019 Sep; 15(9):e1007276. PubMed ID: 31479437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Biological Networks for Drug Target Prediction and Prioritization.
    Ji X; Freudenberg JM; Agarwal P
    Methods Mol Biol; 2019; 1903():203-218. PubMed ID: 30547444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning prediction of oncology drug targets based on protein and network properties.
    Dezső Z; Ceccarelli M
    BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Target Identification with Machine Learning: How to Choose Negative Examples.
    Najm M; Azencott CA; Playe B; Stoven V
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmarking network algorithms for contextualizing genes of interest.
    Hill A; Gleim S; Kiefer F; Sigoillot F; Loureiro J; Jenkins J; Morris MK
    PLoS Comput Biol; 2019 Dec; 15(12):e1007403. PubMed ID: 31860671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug target prediction and repositioning using an integrated network-based approach.
    Emig D; Ivliev A; Pustovalova O; Lancashire L; Bureeva S; Nikolsky Y; Bessarabova M
    PLoS One; 2013; 8(4):e60618. PubMed ID: 23593264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking.
    Gonzalez Gomez C; Rosa-Calatrava M; Fouret J
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38935068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Target Prediction for Small Molecules.
    Byrne R; Schneider G
    Methods Mol Biol; 2019; 1888():273-309. PubMed ID: 30519953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug-target interaction by label propagation with mutual interaction information derived from heterogeneous network.
    Yan XY; Zhang SW; Zhang SY
    Mol Biosyst; 2016 Feb; 12(2):520-31. PubMed ID: 26675534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation Machine Learning for Biological Networks.
    Camacho DM; Collins KM; Powers RK; Costello JC; Collins JJ
    Cell; 2018 Jun; 173(7):1581-1592. PubMed ID: 29887378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmarking network-based gene prioritization methods for cerebral small vessel disease.
    Zhang H; Ferguson A; Robertson G; Jiang M; Zhang T; Sudlow C; Smith K; Rannikmae K; Wu H
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33634312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Drug-Target Network-Based Supervised Machine Learning Repurposing Method Allowing the Use of Multiple Heterogeneous Information Sources.
    Nascimento ACA; Prudêncio RBC; Costa IG
    Methods Mol Biol; 2019; 1903():281-289. PubMed ID: 30547449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window.
    Koutsoukas A; Lowe R; Kalantarmotamedi Y; Mussa HY; Klaffke W; Mitchell JB; Glen RC; Bender A
    J Chem Inf Model; 2013 Aug; 53(8):1957-66. PubMed ID: 23829430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge.
    Ding P; Yin R; Luo J; Kwoh CK
    IEEE J Biomed Health Inform; 2019 May; 23(3):1336-1345. PubMed ID: 29994408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Prediction of Drug-Target Interactions via Ensemble Learning.
    Ezzat A; Wu M; Li X; Kwoh CK
    Methods Mol Biol; 2019; 1903():239-254. PubMed ID: 30547446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INFERENCE OF PERSONALIZED DRUG TARGETS VIA NETWORK PROPAGATION.
    Shnaps O; Perry E; Silverbush D; Sharan R
    Pac Symp Biocomput; 2016; 21():156-67. PubMed ID: 26776182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Computational Methods for Predicting Drug Targets.
    Huang G; Yan F; Tan D
    Curr Protein Pept Sci; 2018; 19(6):562-572. PubMed ID: 27842478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HerGePred: Heterogeneous Network Embedding Representation for Disease Gene Prediction.
    Yang K; Wang R; Liu G; Shu Z; Wang N; Zhang R; Yu J; Chen J; Li X; Zhou X
    IEEE J Biomed Health Inform; 2019 Jul; 23(4):1805-1815. PubMed ID: 31283472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing Drug-Target Interactions with Computational Models and Algorithms.
    Zhou L; Li Z; Yang J; Tian G; Liu F; Wen H; Peng L; Chen M; Xiang J; Peng L
    Molecules; 2019 May; 24(9):. PubMed ID: 31052598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritization of candidate disease genes by enlarging the seed set and fusing information of the network topology and gene expression.
    Zhang SW; Shao DD; Zhang SY; Wang YB
    Mol Biosyst; 2014 Jun; 10(6):1400-8. PubMed ID: 24695957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.